Fig. 1.

Thiocolchicoside suppresses cell proliferation and colony formation of various cancer cell lines. A, the structure of thiocolchicoside. B, thiocolchicoside inhibits cell proliferation of various cancer cell lines. Leukemia (KBM5, Jurkat), colon (HCT-116, Caco-2, HT-29), myeloma (U266, RPMI-8266, MM.1S), breast (MCF-7), squamous (SCC4), and kidney (A293) cells were treated with 25, 50, and 100 μmol/L thiocolchicoside for 1, 3, and 5 d, and cell proliferation was assessed by the MTT method. C, thiocolchicoside has no effect on normal cells. MCF-10A (nontransformed breast epithelial cells) cells and MCF-7 (transformed breast epithelial cells) cells were treated with 25, 50, and 100 μmol/L thiocolchicoside for 24 h, and cell viability was assessed by the MTT method. D, thiocolchicoside inhibits colony formation of HCT-116 cells. HCT-116 cells were plated in six-well plates and treated with 25, 50, and 100 μmol/L of thiocolchicoside for 24 h. After 1 d, medium was changed, and cells were incubated for 9 d for colony formation (top). After 9 d, cells were stained with crystal violet, and number of colonies was counted (bottom). Data are presented as mean (±SD), and * indicates P < 0.05, when compared with control.